113 related articles for article (PubMed ID: 34012011)
1. Germline deletion of chromosome 2p16-21 associated with Lynch syndrome.
Natsume S; Yamaguchi T; Eguchi H; Okazaki Y; Horiguchi SI; Ishida H
Hum Genome Var; 2021 May; 8(1):19. PubMed ID: 34012011
[TBL] [Abstract][Full Text] [Related]
2. Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.
Salo-Mullen EE; Lynn PB; Wang L; Walsh M; Gopalan A; Shia J; Tran C; Man FY; McBride S; Schattner M; Zhang L; Weiser MR; Stadler ZK
Fam Cancer; 2018 Jan; 17(1):71-77. PubMed ID: 28555354
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
[TBL] [Abstract][Full Text] [Related]
4. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
5. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
[TBL] [Abstract][Full Text] [Related]
6. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
7. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
[TBL] [Abstract][Full Text] [Related]
8. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.
Rumilla K; Schowalter KV; Lindor NM; Thomas BC; Mensink KA; Gallinger S; Holter S; Newcomb PA; Potter JD; Jenkins MA; Hopper JL; Long TI; Weisenberger DJ; Haile RW; Casey G; Laird PW; Le Marchand L; Thibodeau SN
J Mol Diagn; 2011 Jan; 13(1):93-9. PubMed ID: 21227399
[TBL] [Abstract][Full Text] [Related]
9. [A novel genetic disorder of Lynch syndrome - EPCAM gene deletion].
Tomita N; Yamano T; Matsubara N; Tamura K
Gan To Kagaku Ryoho; 2013 Feb; 40(2):143-7. PubMed ID: 23411950
[TBL] [Abstract][Full Text] [Related]
10. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
11. Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.
Tutlewska K; Lubinski J; Kurzawski G
Hered Cancer Clin Pract; 2013 Aug; 11(1):9. PubMed ID: 23938213
[TBL] [Abstract][Full Text] [Related]
12. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
Ligtenberg MJ; Kuiper RP; Geurts van Kessel A; Hoogerbrugge N
Fam Cancer; 2013 Jun; 12(2):169-74. PubMed ID: 23264089
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Kuiper RP; Vissers LE; Venkatachalam R; Bodmer D; Hoenselaar E; Goossens M; Haufe A; Kamping E; Niessen RC; Hogervorst FB; Gille JJ; Redeker B; Tops CM; van Gijn ME; van den Ouweland AM; Rahner N; Steinke V; Kahl P; Holinski-Feder E; Morak M; Kloor M; Stemmler S; Betz B; Hutter P; Bunyan DJ; Syngal S; Culver JO; Graham T; Chan TL; Nagtegaal ID; van Krieken JH; Schackert HK; Hoogerbrugge N; van Kessel AG; Ligtenberg MJ
Hum Mutat; 2011 Apr; 32(4):407-14. PubMed ID: 21309036
[TBL] [Abstract][Full Text] [Related]
14. Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers.
Nagasaka T; Rhees J; Kloor M; Gebert J; Naomoto Y; Boland CR; Goel A
Cancer Res; 2010 Apr; 70(8):3098-108. PubMed ID: 20388775
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.
Pirini F; Tedaldi G; Danesi R; Cangini I; Tumedei MM; Ferrari A; Vitali S; De Maio G; Terragna C; Solli V; Tebaldi M; Puccetti M; Zampiga V; Ravegnani M; Ulivi P; Falcini F; Martinelli G; Calistri D
Int J Colorectal Dis; 2019 Nov; 34(11):1999-2002. PubMed ID: 31655866
[TBL] [Abstract][Full Text] [Related]
16. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.
Mork ME; Rodriguez A; Taggart MW; Rodriguez-Bigas MA; Lynch PM; Bannon SA; You YN; Vilar E
Fam Cancer; 2017 Jul; 16(3):357-361. PubMed ID: 28004223
[TBL] [Abstract][Full Text] [Related]
17. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
[TBL] [Abstract][Full Text] [Related]
18. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.
Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G
Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899
[TBL] [Abstract][Full Text] [Related]
19. Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population.
Rhees J; Arnold M; Boland CR
Fam Cancer; 2014 Jun; 13(2):219-25. PubMed ID: 24114314
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion.
Sekine S; Ogawa R; Saito S; Ushiama M; Shida D; Nakajima T; Taniguchi H; Hiraoka N; Yoshida T; Sugano K
Histopathology; 2017 Mar; 70(4):664-669. PubMed ID: 27896849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
